These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23752471)

  • 1. Arylsulfonylamino-benzanilides as inhibitors of the apical sodium-dependent bile salt transporter (SLC10A2).
    Liu HT; He HW; Bai XG; Wang JX; Xu CL; Cai SY; Shao RG; Wang YC
    Molecules; 2013 Jun; 18(6):6883-97. PubMed ID: 23752471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of substrate specificity for the bile salt transporter ASBT (SLC10A2).
    Lionarons DA; Boyer JL; Cai SY
    J Lipid Res; 2012 Aug; 53(8):1535-42. PubMed ID: 22669917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory Effect of Theaflavins on Apical Sodium-Dependent Bile Acid Transporter (ASBT) Activity.
    Takashima Y; Ishikawa K; Miyawaki R; Ogawa M; Ishii T; Misaka T; Kobayashi S
    J Agric Food Chem; 2021 Aug; 69(33):9585-9596. PubMed ID: 34346218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter.
    Zheng X; Ekins S; Raufman JP; Polli JE
    Mol Pharm; 2009; 6(5):1591-603. PubMed ID: 19673539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel class of apical sodium-dependent bile acid transporter inhibitors: the amphiphilic 4-oxo-1-phenyl-1,4-dihydroquinoline derivatives.
    Kurata H; Suzuki S; Ohhata Y; Ikeda T; Hasegawa T; Kitayama K; Inaba T; Kono K; Kohama T
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1183-6. PubMed ID: 14980661
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ticho AL; Malhotra P; Manzella CR; Dudeja PK; Saksena S; Gill RK; Alrefai WA
    J Biol Chem; 2020 Apr; 295(14):4488-4497. PubMed ID: 32071081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
    Tremont SJ; Lee LF; Huang HC; Keller BT; Banerjee SC; Both SR; Carpenter AJ; Wang CC; Garland DJ; Huang W; Jones C; Koeller KJ; Kolodziej SA; Li J; Manning RE; Mahoney MW; Miller RE; Mischke DA; Rath NP; Fletcher T; Reinhard EJ; Tollefson MB; Vernier WF; Wagner GM; Rapp SR; Beaudry J; Glenn K; Regina K; Schuh JR; Smith ME; Trivedi JS; Reitz DB
    J Med Chem; 2005 Sep; 48(18):5837-52. PubMed ID: 16134950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT).
    Xiao L; Pan G
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):509-515. PubMed ID: 28336180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apical Sodium-Dependent Bile Acid Cotransporter, A Novel Transporter of Indocyanine Green, and Its Application in Drug Screening.
    Wu MR; Hsiao JK
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32209977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery.
    Yang N; Dong YQ; Jia GX; Fan SM; Li SZ; Yang SS; Li YB
    Biomed Pharmacother; 2020 Dec; 132():110835. PubMed ID: 33035828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).
    Ho RH; Leake BF; Urquhart BL; Gregor JC; Dawson PA; Kim RB
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1740-8. PubMed ID: 21649730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges.
    Li M; Wang Q; Li Y; Cao S; Zhang Y; Wang Z; Liu G; Li J; Gu B
    Pharmacol Ther; 2020 Aug; 212():107539. PubMed ID: 32201314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT.
    Annaba F; Kumar P; Dudeja AK; Saksena S; Gill RK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G467-73. PubMed ID: 20056894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 1,2-benzothiazepines.
    Tollefson MB; Kolodziej SA; Fletcher TR; Vernier WF; Beaudry JA; Keller BT; Reitz DB
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3727-30. PubMed ID: 14552767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucuronidation converting methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a potent apical sodium-dependent bile acid transporter inhibitor, resulting in a hypocholesterolemic action.
    Sakamoto S; Kusuhara H; Miyata K; Shimaoka H; Kanazu T; Matsuo Y; Nomura K; Okamura N; Hara S; Horie K; Baba T; Sugiyama Y
    J Pharmacol Exp Ther; 2007 Aug; 322(2):610-8. PubMed ID: 17470645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters.
    Ge MX; Niu WX; Ren JF; Cai SY; Yu DK; Liu HT; Zhang N; Zhang YX; Wang YC; Shao RG; Wang JX; He HW
    Acta Pharmacol Sin; 2019 Jul; 40(7):895-907. PubMed ID: 30573812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2).
    Chothe PP; Swaan PW
    Biochem J; 2014 Apr; 459(2):301-12. PubMed ID: 24498857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
    van der Mark VA; de Waart DR; Ho-Mok KS; Tabbers MM; Voogt HW; Oude Elferink RP; Knisely AS; Paulusma CC
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2378-86. PubMed ID: 25239307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
    Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
    J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys.
    Kitayama K; Nakai D; Kono K; van der Hoop AG; Kurata H; de Wit EC; Cohen LH; Inaba T; Kohama T
    Eur J Pharmacol; 2006 Jun; 539(1-2):89-98. PubMed ID: 16687134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.